13F HOLDINGS REPORT
Finepoint Capital LP
Quarter ended Q1 2025 · Filed May 14, 2025 · Accession 0000904454-25-000272
Total Value
$1.31B
Positions
25
Other Managers
0
Confidential Omitted
No
Holdings (25)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | SPDR S&P 500 ETF TR | SPY | 755,000 | $422.2M | 32.20% |
| 2 | QXO INC | QXO-PB | 24,468,160 | $331.3M | 25.27% |
| 3 | ISHARES TR | 464287655 | 1,485,000 | $296.3M | 22.59% |
| 4 | Liberty Broadband Corp | LBRDP | 529,240 | $45.0M | 3.43% |
| 5 | SPRINGWORKS THERAPEUTICS INC | 85205L107 | 728,602 | $32.2M | 2.45% |
| 6 | LIBERTY MEDIA CORP DEL | FWONB | 432,895 | $29.5M | 2.25% |
| 7 | ASCENDIS PHARMA A/S | ASND | 179,872 | $28.0M | 2.14% |
| 8 | REVOLUTION MEDICINES INC | RVMDW | 691,260 | $24.4M | 1.86% |
| 9 | MoonLake Immunotherapeutics | MLTX | 435,785 | $17.0M | 1.30% |
| 10 | GALAPAGOS NV | GLPGF | 656,587 | $16.5M | 1.26% |
| 11 | CYTOKINETICS INC | CYTK | 309,948 | $12.5M | 0.95% |
| 12 | AVIDITY BIOSCIENCES INC | 05370A108 | 380,700 | $11.2M | 0.86% |
| 13 | SAREPTA THERAPEUTICS INC | SRPT | 157,555 | $10.1M | 0.77% |
| 14 | PROTHENA CORP PLC | PRTA | 640,071 | $7.9M | 0.60% |
| 15 | XENCOR INC | XNCR | 642,200 | $6.8M | 0.52% |
| 16 | EYEPOINT PHARMACEUTICALS INC | EYPT | 1,081,954 | $5.9M | 0.45% |
| 17 | RELAY THERAPEUTICS INC | RLAY | 2,117,646 | $5.5M | 0.42% |
| 18 | ARVINAS INC | ARVN | 694,028 | $4.9M | 0.37% |
| 19 | SOLID BIOSCIENCES INC | SLDB | 961,251 | $3.6M | 0.27% |
| 20 | ALEANNA INC | ANNAW | 27,717 | $208,709 | 0.02% |
| 21 | ALEANNA INC | ANNAW | 490,000 | $122,451 | 0.01% |
| 22 | Marblegate Acquisition Corp | 56608A113 | 735,000 | $117,600 | 0.01% |
| 23 | MONEYHERO LIMITED | MNYWW | 895,000 | $32,847 | 0.00% |
| 24 | LAKESHORE BIOPHARMA CO LTD | G9845F117 | 489,999 | $20,237 | 0.00% |
| 25 | CALIDI BIOTHERAPEUTICS INC | CLDWW | 12,499 | $7,077 | 0.00% |